Selected article for: "attack rate and vaccine coverage"

Author: Wu, Joseph T.; Peak, Corey M.; Leung, Gabriel M.; Lipsitch, Marc
Title: Fractional Dosing of Yellow Fever Vaccine to Extend Supply: A Modeling Study
  • Document date: 2016_11_10
  • ID: 02pjdufw_35
    Snippet: Given the global shortage of YF vaccines, an additional benefit of fractionated dosing is to extend coverage to a wider geographic area, covering more populations with vaccine than could be achieved with standard dosing. Indeed, part of the WHO plan is to vaccinate border areas between Angola and Congo 25 , providing benefit to that population as well as an "immune buffer" to slow movement of disease toward Kinshasa. 26 We conclude that dose frac.....
    Document: Given the global shortage of YF vaccines, an additional benefit of fractionated dosing is to extend coverage to a wider geographic area, covering more populations with vaccine than could be achieved with standard dosing. Indeed, part of the WHO plan is to vaccinate border areas between Angola and Congo 25 , providing benefit to that population as well as an "immune buffer" to slow movement of disease toward Kinshasa. 26 We conclude that dose fractionation could be a very effective strategy for improving coverage of YF vaccines and reducing infection attack rate in populations --possibly by a large absolute and relative margin --if high to moderate efficacy is maintained by reduceddose formulations. For vaccines whose standard formulations exceed WHO minimum concentration of viral particles, 10 this dose fractionation could be accomplished without changing the WHO recommendations. In particular, the WHO plan to use fractional dosing to extend the coverage of vaccination within Kinshasa and in surrounding areas is robust in the sense that it is expected to provide greater benefit than the use of full dosages, even if, counter to current evidence, efficacy of fractionated doses is substantially lower than that of standard doses.

    Search related documents:
    Co phrase search for related documents
    • additional benefit and current evidence: 1, 2, 3
    • additional benefit and standard formulation: 1
    • additional benefit and vaccination coverage: 1
    • additional benefit and vaccine population: 1
    • benefit provide and current evidence: 1, 2, 3, 4, 5, 6, 7, 8
    • benefit provide and disease movement: 1
    • benefit provide and dose fractionation: 1, 2, 3
    • benefit provide and effective strategy: 1, 2, 3
    • benefit provide and fractional dose: 1, 2
    • benefit provide and great benefit: 1, 2, 3, 4
    • benefit provide and infection attack: 1
    • benefit provide and infection attack rate: 1
    • benefit provide and standard dose: 1, 2
    • benefit provide and standard dosing: 1, 2
    • benefit provide and vaccination coverage: 1, 2
    • benefit provide and vaccine population: 1, 2
    • benefit provide and YF vaccine: 1